The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension
Open accessAbstract
Intensive care of patients with pulmonary hypertension (PH) and right-sided heart failure includes treatment of factors causing or contributing to heart failure, careful fluid management, and strategies to reduce ventricular afterload and improve cardiac function. Extracorporeal membrane oxygenation (ECMO) should be considered in distinct situations, especially in candidates for lung transplantation (bridge to transplant) or, occasionally, in patients with a reversible cause of right-sided heart failure (bridge to recovery). ECMO should not be used in patients with end-stage disease without a realistic chance for recovery or for transplantation. For patients with refractory disease, lung transplantation remains an important treatment option. Patients should be referred to a transplant centre when they remain in an intermediate- or high-risk category despite receiving optimised pulmonary arterial hypertension therapy. Meticulous peri-operative management including the intra-operative and post-operative use of ECMO effectively prevents graft failure. In experienced centres, the 1-year survival rates after lung transplantation for PH now exceed 90%.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIGURE 1 Therapeutic approach to patients with severe right-sided heart failure. RV: right ventricular; PAH: pulmonary arterial hypertension; NO: nitric oxide; ECMO: extracorporeal membrane oxygenation; ECLS: extracorporeal lung support. Reproduced and modified from [80] with permission.](https://figures.cochat.ai/paper-figures/ec7f9b6c298d408b99223dc09199f5ea/intensive-care-right-ventricular-support-and-lung-transplantation-in-patients-figure-1.jpg)
![FIGURE 2 Effects on volume changes on cardiac function in right-sided heart failure. RV: right ventricle; LV: left ventricle; RVEDP: right ventricular end-diastolic pressure; TR: tricuspid regurgitation; CO: cardiac output. Reproduced and modified from [80] with permission.](https://figures.cochat.ai/paper-figures/e98ad229118d42d9a16db3d087540b1e/intensive-care-right-ventricular-support-and-lung-transplantation-in-patients-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Early consideration of transplant should be emphasized for patients with PAH, as referral of patients at the onset of clinical deterioration may not provide enough time to complete the evaluation and to obtain a suitable donor organ (275).”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [275]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationGaliè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationMullens, W., Abrahams, Z., Francis, G. S., Sokos, G., Taylor, D. O., Starling, R. C., Young, J. B., & Tang, W. H. W. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.068 · Cited by 1,674
Weill, D., Benden, C., Corris, P. A., Dark, J. H., Davis, R. D., Keshavjee, S., Lederer, D. J., Mulligan, M. J., Patterson, G. A., Singer, L. G., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.06.014 · Cited by 1,329
Self-citationEndotoxin and immune activation in chronic heart failure: a prospective cohort study
Niebauer, J., Volk, H.-D., Kemp, M., Dominguez, M., Schumann, R. R., Rauchhaus, M., Poole-Wilson, P. A., Coats, A. J., & Anker, S. D. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09286-1 · Cited by 877
Heart-Lung Transplantation: Successful Therapy for Patients with Pulmonary Vascular Disease
Reitz, B. A., Wallwork, J. L., Hunt, S. A., Pennock, J. L., Billingham, M. E., Oyer, P. E., Stinson, E. B., & Shumway, N. E. (1982) · New England Journal of Medicine · doi:10.1056/nejm198203113061001 · Cited by 849
Harjola, V.-P., Mebazaa, A., Čelutkienė, J., Bettex, D., Bueno, H., Chioncel, O., Crespo-Leiro, M. G., Falk, V., Filippatos, G., Gibbs, S., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.478 · Cited by 720
Christie, J. D., Edwards, L. B., Kucheryavaya, A. Y., Aurora, P., Dobbels, F., Kirk, R., Rahmel, A. O., Stehlik, J., & Hertz, M. I. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.08.004 · Cited by 674
Hoeper, M. M., Kramer, T., Pan, Z., Eichstaedt, C. A., Spiesshoefer, J., Benjamin, N., Olsson, K. M., Meyer, K., Vizza, C. D., Vonk-Noordegraaf, A., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00740-2017 · Cited by 660
Self-citationExtracorporeal Membrane Oxygenation in Awake Patients as Bridge to Lung Transplantation
Fuehner, T., Kuehn, C., Hadem, J., Wiesner, O., Gottlieb, J., Tudorache, I., Olsson, K. M., Greer, M., Sommer, W., Welte, T., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201109-1599oc · Cited by 601
Self-citation
Cited by
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac237 · Cited by 3,975
Self-citation2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00879-2022 · Cited by 2,247
Self-citationRisk stratification and medical therapy of pulmonary arterial hypertension
Galiè, N., Channick, R. N., Frantz, R. P., Grünig, E., Jing, Z. C., Moiseeva, O., Preston, I. R., Pulido, T., Safdar, Z., Tamura, Y., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01889-2018 · Cited by 819
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
An overview of the 6th World Symposium on Pulmonary Hypertension
Galiè, N., McLaughlin, V. V., Rubin, L. J., & Simonneau, G. (2019) · European Respiratory Journal · doi:10.1183/13993003.02148-2018 · Cited by 526
Pulmonary Hypertension: A Brief Guide for Clinicians
Mandras, S. A., Mehta, H. S., & Vaidya, A. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.04.039 · Cited by 271
“Management of comorbidities (eg, sleep apnea and COPD) is essential in all patients with PH, and patients in any group may require supportive therapies such as diuretics, oxygen, and management of HF, including treatment of aggravating factors, optimization of fluid status, reduction of RV afterload, and cardiac inotr…”
BackgroundMechanisms and treatment of pulmonary arterial hypertension
Ghofrani, H. A., Gomberg‐Maitland, M., Zhao, L., & Grimminger, F. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01064-4 · Cited by 134
“Although the primary disorder in PAH is in the pulmonary vasculature rather than in the right ventricle (which almost always recovers after lung transplantation 224 ), RV function has a crucial role in determining patient outcomes 4 .”
Price, L., Martinez, G. C., Brame, A., Pickworth, T., Samaranayake, C. B., Alexander, D. J., Garfield, B. E., Aw, T., McCabe, C., Mukherjee, B., et al. (2021) · British Journal of Anaesthesia · doi:10.1016/j.bja.2021.01.005 · Cited by 113
Evaluation and management of pulmonary arterial hypertension
Beshay, S. M., Sahay, S., & Humbert, M. J. C. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.106099 · Cited by 111
Guidelines for the Treatment of Pulmonary Arterial Hypertension
Vazquez, Z. G. S., & Klinger, J. R. (2020) · Lung · doi:10.1007/s00408-020-00375-w · Cited by 80
Avdeev, S. N., Барбараш, О. Л., Солтановна, В. З., Volkov, A. V., Veselova, T. N., Galyavich, A. S., Goncharova, N. S., Gorbachevsky, S. V., Владимирович, Г. В., Danilov, N. M., et al. (2024) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2024-6161 · Cited by 85
Adult congenital heart disease and the COVID-19 pandemic
Radke, R., Frenzel, T., Baumgartner, H., & Diller, G. (2020) · Heart · doi:10.1136/heartjnl-2020-317258 · Cited by 68
Care of patients with pulmonary arterial hypertension during the coronavirus (COVID‐19) pandemic
Ryan, J. J., Melendres-Groves, L. D., Zamanian, R. T., Oudiz, R. J., Chakinala, M. M., Rosenzweig, E. B., & Gomberg‐Maitland, M. (2020) · Pulmonary Circulation · doi:10.1177/2045894020920153 · Cited by 67
“Intubation can be fatal in PAH if performed and managed improperly.(8,16) Plus extubation post-treatment in the PAH patient 4 | COVID-19 and PAH Ryan et al.”
BackgroundMethodMcGlothlin, D. P., Granton, J. T., Klepetko, W., Beghetti, M., Rosenzweig, E. B., Corris, P. A., Horn, E. M., Kanwar, M. K., McRae, K. M., Román, A., et al. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.06.013 · Cited by 74
“This flow rate is enough to allow unloading of the right ventricle, preservation of pulmonary blood flow and adequate systemic oxygen delivery while avoiding overload of the left heart that may have secondary dysfunction in patients with severe RV failure.(62,84) A retained PAC can confirm achievement of these goals.”
BackgroundSelf-citationPulmonary arterial hypertension
Boucly, A., Gerges, C., Savale, L., Jaïs, X., Jevnikar, M., Montani, D., Sitbon, O., & Humbert, M. J. C. (2023) · La Presse Médicale · doi:10.1016/j.lpm.2023.104168 · Cited by 63
Self-citationXiao, Y., Chen, P., Zhou, R.-L., Zhang, Y., Tian, Z., & Zhang, S. (2020) · Aging and Disease · doi:10.14336/ad.2020.0111 · Cited by 60
“Pumpless membrane oxygenators inserted between the pulmonary artery and the pulmonary veins or left atrium (PA-LA) and CardioMEMS are also an alternative therapeutic option [107, 108].”
BackgroundGlorion, M., Mercier, O. M., Mitilian, D., de Lemos, A., Lamrani, L., Feuillet, S., Pradère, P., Pavec, J. L., Lehouerou, D., Stéphan, F., et al. (2018) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy089 · Cited by 57
Self-citationVizza, C. D., Lang, I. M., Badagliacca, R., Benza, R. L., Rosenkranz, S., White, R. J., Adir, Y., Andreassen, A. K., Balasubramanian, V. P., Bartolome, S., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202109-2079pp · Cited by 56
“Of note, the right ventricle recovers within a few weeks after transplantation regardless of the degree of pretransplant dilatation, dysfunction, and preoperative tricuspid regurgitation (19).”
BackgroundSelf-citationPostoperative Management of Lung Transplant Recipients in the Intensive Care Unit
Nardo, M. D., Tikkanen, J., Husain, S., Singer, L. G., Cypel, M., Ferguson, N. D., Keshavjee, S. H., & Sorbo, L. D. (2021) · Anesthesiology · doi:10.1097/aln.0000000000004054 · Cited by 66
Avdeev, S. N., Барбараш, О. Л., Баутин, А. Е., Volkov, A. V., Veselova, T. N., Galyavich, A. S., Goncharova, N. S., Gorbachevsky, S. V., Danilov, N. M., Еременко, А. А., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4683 · Cited by 60
Pulmonary Hypertension Associated with Connective Tissue Disease
Fayed, H., & Coghlan, G. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1685214 · Cited by 48
Transplantation, bridging, and support technologies in pulmonary hypertension
Savale, L., Benazzo, A., Corris, P. A., Keshavjee, S. H., Levine, D. J., Mercier, O. M., Davis, R. D., & Granton, J. T. (2024) · European Respiratory Journal · doi:10.1183/13993003.01193-2024 · Cited by 53
“…management of RHF have not changed significantly since the 6th World Symposium on Pulmonary Hypertension [8], there has been a rapid expansion in the utilisation of rescue strategies such as mechanical circulatory support and urgent transplantation in patients with refractory RHF [8, 11, 17 – 22].”
InfluentialSelf-citationImpact of high-priority allocation on lung and heart-lung transplantation for pulmonary hypertension
Savale, L., Le Pavec, J., Mercier, O., Mussot, S., Jaïs, X., Fabre, D., O’Connell, C., Montani, D., Stephan, F., Sitbon, O., et al. (2017) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2017.02.034 · Cited by 42
Self-citationExpert management of congenital portosystemic shunts and their complications
McLin, V. A., Franchi‐Abella, S., Brütsch, T., Bahadori, A., Casotti, V., de Goyet, J. D. V., Dumery, G., Gonzales, E. M., Guérin, F., Hascoët, S., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100933 · Cited by 42
Self-citationBoehm, M., Tian, X., Mao, Y., Ichimura, K., Dufva, M. J., Ali, M. K., Prosseda, S. D., Shi, Y., Kuramoto, K., Reddy, S., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz310 · Cited by 45
Oxygen Supplementation and Hyperoxia in Critically Ill Cardiac Patients
Thomas, A. W., van Diepen, S., Beekman, R. B., Sinha, S. S., Brusca, S. B., Alviar, C. L., Jentzer, J. C., Bohula, E. A., Katz, J. N., Shahu, A., et al. (2022) · JACC Advances · doi:10.1016/j.jacadv.2022.100065 · Cited by 44
JCS 2022 Guideline on Perioperative Cardiovascular Assessment and Management for Non-Cardiac Surgery
Hiraoka, E., Tanabe, K., Izuta, S., Kubota, T., Kohsaka, S., Kozuki, A., Satomi, K., Shiomi, H., Shinke, T., Nagai, T., et al. (2023) · Circulation Journal · doi:10.1253/circj.cj-22-0609 · Cited by 48
Lung Transplantation for Pulmonary Arterial Hypertension
Kolaitis, N. A. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.04.047 · Cited by 38
Kocken, J. M. M., & Martins, P. A. D. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238901 · Cited by 31
“The ultimate treatment option available is either lung transplantation, combined with RV support, or palliative support if long-term treatment options are no longer available or possible [82,83].”
Backgroundthe Canadian CTEPH Working Group, de Perrot, M. E., McRae, K. M., Donahoe, L. L., Abdelnour‐Berchtold, E., Thenganatt, J., & Granton, J. T. (2022) · Annals of Cardiothoracic Surgery · doi:10.21037/acs-2021-pte-14 · Cited by 32
“These difficulties are reminiscent of those seen in patients undergoing bilateral lung transplantation for end-stage pulmonary arterial hypertension, where the risk of pulmonary edema is particularly high and the operative mortality is generally greater than 10% (13).”
BackgroundAnesthetic management of lung transplantation: impact of presenting disease
Martin, A. K., Fritz, A. V., & Wilkey, B. (2019) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000805 · Cited by 29
“Peripheral cannulation is associated with increased risks including infection, vascular damage, or differential body oxygenation secondary to blood flow mixing (Harlequin syndrome) [43,46,47].”
BackgroundEurasian guidelines for the diagnosis and treatment of pulmonary hypertension (2023)
Chazova, I. E., Martynyuk, T. V., Shmalts, A. A., Владимирович, Г. В., Danilov, N. M., Veselova, T. N., Захаровна, К. И., Шогаибович, С. А., Стукалова, О. В., Азизов, В. А., et al. (2024) · Eurasian heart journal · doi:10.38109/2225-1685-2024-1-6-85 · Cited by 38
International Liver Transplantation Society practice guideline update on portopulmonary hypertension
DuBrock, H. M., Savale, L., Sitbon, O., Raevens, S., Kawut, S. M., Fallon, M. B., Heimbach, J. K., Chadha, R., Crespo, G., Ramsay, M. A. E., et al. (2025) · Liver Transplantation · doi:10.1097/lvt.0000000000000600 · Cited by 36
“[65,68] The evolving use of extracorporeal membrane oxygenation (ECMO) in LT, including for patients with POPH, has been recently reviewed.”
Self-citationBauchmüller, K., Condliffe, R., Southern, J., Billings, C., Charalampopoulos, A. F., Elliot, C. A., Hameed, A. G., Kiely, D. G., Sabroe, I., Thompson, A. A. R., et al. (2021) · ERJ Open Research · doi:10.1183/23120541.00046-2021 · Cited by 25
Advanced airway management and respiratory care in decompensated pulmonary hypertension
Vahdatpour, C., Ryan, J. J., Zimmerman, J., MacCormick, S., Palevsky, H. I., Alnuaimat, H., & Ataya, A. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10168-9 · Cited by 27
“Expert opinion suggests that norepinephrine or vasopressin should be considered as first-line vasopressor in dPH patients [15].”
BackgroundInfluentialAtrial arrhythmias in chronic lung disease‐associated pulmonary hypertension
Vahdatpour, C., Luebbert, J. J., & Palevsky, H. I. (2020) · Pulmonary Circulation · doi:10.1177/2045894020910685 · Cited by 24
“Patients with severe PH requiring CCA should have the procedure performed under specialist cardiac anesthesia, and general expert opinion recommends that mechanical ventilation in combination with deep sedation and/or general anesthesia during severe ARF should be avoided, if possible.(98)”
BackgroundInterventional and Surgical Treatments for Pulmonary Arterial Hypertension
Stącel, T., Latos, M., Urlik, M., Nęcki, M., Antończyk, R., Hrapkowicz, T., Kurzyna, M., & Ochman, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153326 · Cited by 24
The Roles of Venopulmonary Arterial Extracorporeal Membrane Oxygenation
Hockstein, M. A., & Fan, E. (2023) · Critical Care Medicine · doi:10.1097/ccm.0000000000006094 · Cited by 21
“Given the potential for prolonged ICU stays awaiting lung transplantation, many patients may incur complications such as deconditioning and sepsis (23).”
BackgroundZhang, H., Liu, Q., Piao, C., Zhu, Y., Li, Q., Du, J., & Gu, H. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.07.628 · Cited by 20
Mechanical circulatory support devices and treatment strategies for right heart failure
Kuroda, T., Miyagi, C., Fukamachi, K., & Karimov, J. H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.951234 · Cited by 18
Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs
Jin, Q., Chen, D., Zhang, X., Zhang, F., Zhong, D., Lin, D., Guan, L., Pan, W., Zhou, D., & Ge, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061579 · Cited by 21
“Gastrointestinal edema can lead to digestive problems and malabsorption, interfere with the absorption and utilization of targeted agents, and thus affect their efficacy [30].”
BackgroundInfluentialLung transplantation for pulmonary hypertension
Hwalek, A. E., Rosenheck, J. P., & Whitson, B. A. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-2021-20 · Cited by 19
“ECMO techniques have been increasingly deployed as a bridge to transplantation (31,34-37), and patients can be maintained on ECLS for long periods of time (35), though ongoing mobilization and conditioning are important when choosing vascular access sites.”
Girardis, M., Béttex, D., Bojan, M., Demponeras, C., Fruhwald, S. M., Gál, J., Groesdonk, H. V., Guarracino, F., Guerrero-Orriach, J. L., Heringlake, M., et al. (2022) · Journal of Anesthesia Analgesia and Critical Care · doi:10.1186/s44158-021-00030-7 · Cited by 17
Vaidy, A., O’Corragain, O. A., & Vaidya, A. (2023) · Critical Care Clinics · doi:10.1016/j.ccc.2023.05.003 · Cited by 15
Vicaire, H., Pavec, J. L., Mercier, O. M., Montani, D., Boucly, A., Roche, A., Pradère, P., Dauriat, G., Feuillet, S., Pichon, J., et al. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.06.001 · Cited by 16
Self-citationRefined risk stratification in pulmonary arterial hypertension and timing of lung transplantation
Olsson, K. M., Richter, M. J., Kamp, J. C., Gall, H. J., Ghofrani, H. A., Fuge, J., Ewert, R., & Hoeper, M. M. (2022) · European Respiratory Journal · doi:10.1183/13993003.03087-2021 · Cited by 15
Self-citationQu, C., Feng, W., Zhao, Q., Liu, Q., Luo, X., Wang, G., Sun, M., Yao, Z., Sun, Y., Hou, S., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.778620 · Cited by 14
“Treatment of triggering factors, careful fluid management, and measures to restore cardiac function and minimize right ventricular afterload are the foundations of intensive care for acute decompensated PAH (7).”
BackgroundCritical Care Management of the Patient with Pulmonary Hypertension
Mullin, C. J., & Ventetuolo, C. E. (2021) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.11.009 · Cited by 16
Critical care management of the patient with pulmonary hypertension
Barnett, C. F., O’Brien, C., & Marco, T. D. (2021) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuab113 · Cited by 19
Management of Pulmonary Arterial Hypertension in the ICU
Torbic, H. (2019) · Journal of Pharmacy Practice · doi:10.1177/0897190019838110 · Cited by 14
“This decrease in CO then leads to decreased systemic blood pressure and decreased perfusion of the RV, thereby further decreasing CO. PVR may also be increased by positive pressure ventilation due to increased lung volumes and distended alveoli compressing alveolar blood vessels.49,62 Medications used peri-intubation…”
BackgroundMethodInfluentialReed, A. K., Mercier, O. M., Behr, J., Dave, K., Dellgren, G., Kotecha, S., Kukreja, J., Landry, C., Levvey, B. J., Lyster, H. S., et al. (2025) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2025.07.033 · Cited by 18
Bermudez, C. A., Crespo, M. M., Shlobin, O. A., Cantu, E., Mazurek, J. A., Levine, D. J., Gutsche, J. T., Kanwar, M. K., Dellgren, G., Bush, E. L., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.016 · Cited by 14
“The failing right ventricle is extremely sensitive to fluctuations in pre-load or increases in afterload.(43,69) Principles of anesthetic management in the presence of pulmonary hypertension are essential to prevent hemodynamic collapse.”
BackgroundPerioperative approach to precapillary pulmonary hypertension in non-cardiac non-obstetric surgery
Bandyopadhyay, D., Lai, C., Pulido, J. N., Restrepo‐Jaramillo, R., Tonelli, A. R., & Humbert, M. J. C. (2021) · European Respiratory Review · doi:10.1183/16000617.0166-2021 · Cited by 14
Medical and Mechanical Circulatory Support of the Failing Right Ventricle
Yuriditsky, E., CHONDE, M. D., Friedman, O., & Horowitz, J. M. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-02012-3 · Cited by 12
“Its use in patients with pulmonary arterial hypertension bridged to lung transplant is limited to small case series with survival rates of 50–100% [65].”
Exposto, F., Petrica, N., Davies, E. W., & Beaudet, A. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.02.034 · Cited by 12
Outcomes of cardiopulmonary resuscitation in patients with pulmonary arterial hypertension
Yang, J. Z., Odish, M. F., Mathers, H., Pebley, N., Wardi, G., Papamatheakis, D. G., Poch, D. S., Kim, N. H., Fernandes, T. M., & Sell, R. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12066 · Cited by 11
“Although VA‐ECMO may serve as a bridge to lung transplant in select patients with PAH, it usually cannot be used successfully as a bridge to recovery, unless there is a clear acute and reversible cause to decompensation.(22) In a decompensating PAH patient who is a lung transplant candidate, there should be early cons…”
BackgroundSavale, L., Vuillard, C., Pichon, J., Boucly, A., Roche, A., Jevnikar, M., Ebstein, N., Jaïs, X., Pavec, J. L., Montani, D., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.00466-2021 · Cited by 13
Self-citationTorbic, H., Hohlfelder, B., Krishnan, S., & Tonelli, A. R. (2022) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/10742484211069005 · Cited by 11
“Some of these patients may be candidates for extracorporeal membrane oxygenation (ECMO) support, including candidates for lung transplantation as a bridge to transplant or in patients with a potentially reversible cause of right-sided heart failure as a bridge to recovery.(7,8) ICU admission for pulmonary hypertension…”
BackgroundThe Lung Transplant Candidate, Indications, Timing, and Selection Criteria
Mannem, H. C., Aversa, M. M., Keller, T., & Kapnadak, S. G. (2023) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.10.001 · Cited by 13
Kolaitis, N. A., Barnes, H., Levine, D. J., Castillo, H., Arcasoy, S. M., Bacchetta, M. D., Benvenuto, L. J., Rosenzweig, E. B., Cevasco, M., Demarest, C. T., et al. (2025) · Pulmonary Circulation · doi:10.1002/pul2.70088 · Cited by 12
Self-citationManagement of hospitalized patients with pulmonary arterial hypertension and COVID‐19 infection
Sahay, S., & Farber, H. W. (2020) · Pulmonary Circulation · doi:10.1177/2045894020933480 · Cited by 10
“published literature.(19,27) We recommend continuing treatment with investigational therapies for COVID-19 infection as per institutional guidelines along with the PAH treatment.”
MethodTopic-Based, Recent Literature Review on Pulmonary Hypertension
Burger, C. D., DuBrock, H. M., Cartin‐Ceba, R., Moss, J. E., Shapiro, B. P., & Frantz, R. P. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.05.026 · Cited by 12
Right Ventricular Failure and Pulmonary Hypertension
Crager, S. E., & Humphreys, C. (2022) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2022.05.006 · Cited by 10
Predictors of survival in patients with pulmonary hypertension and acute right heart failure
Ambrož, D., Jansa, P., Kuchař, J., Bělohlávek, J., Aschermann, M., Dytrych, V., Lindner, J., Šimková, I., & Linhart, A. (2020) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2020_035 · Cited by 10
“Neither the conclusions from the 6th World Symposium on Pulmonary Hypertension 2018 in Nice (1) nor the valid E S C Guidelines for the diagnosis and treatment of acute and chronic heart failure from 2016 (10) are dealing wi t h the therapy of ARHF patients who are hemodynamically stable without clear clinical or labor…”
BackgroundManagement of COVID-19 in Patients with Pulmonary Arterial Hypertension
Farmakis, I. T., & Giannakoulas, G. A. (2022) · Heart Failure Clinics · doi:10.1016/j.hfc.2022.07.003 · Cited by 10
Critical Care Management Following Lung Transplantation
Jeon, K. (2022) · The Korean Journal of Thoracic and Cardiovascular Surgery · doi:10.5090/jcs.22.067 · Cited by 13
“Bridging this period with veno-arterial ECMO has been described for the postoperative management of recipients with severe pulmonary hypertension as a way to specifically address these issues and allow time for recovery of the “deconditioned” LV, which can take several days [51-54].”
BackgroundThe evolving role of interventional cardiology in the treatment of pulmonary hypertension
Gurevich, S. G., & Prins, K. W. (2020) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29146 · Cited by 9
“Surgical approaches offer another invaluable tool for PH management as pulmonary thromboendarterectomy (PTE) can be curative in CTEPH,(11) and lung transplantation is used for end-stage PH patients.(12) However, medical therapy has not clearly improved survival in PAH and CTEPH,(2) and as many as 35–40% of CTEPH patie…”
MethodManagement of arrhythmias in pulmonary hypertension
Reddy, S. A., Nethercott, S. L., Khialani, B. V., Grace, A. A., & Martin, C. (2021) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-021-00988-y · Cited by 13
Granton, J. T., & Teijeiro‐Paradis, R. (2022) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.04.005 · Cited by 9
Medical Management of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
Caputo, A., Papa, S., Manzi, G., Laviola, D., Recchioni, T., Severino, P., Lavalle, C., Maestrini, V., Mancone, M., Badagliacca, R., et al. (2023) · Current Heart Failure Reports · doi:10.1007/s11897-023-00612-2 · Cited by 8
“An important clue of the clinical relevance of achieving RHRR can be found in PAH patients undergoing lung transplantation, where early post-transplant normalization of mean pulmonary arterial pressure (mPAP), pulmonary vascular resistance (PVR), and right ventricular ejection fraction was observed during the follow-u…”
BackgroundLung transplantation: candidate selection and timing of transplant
Shah, P., & Neujahr, D. C. (2021) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000879 · Cited by 8
Epoprostenol for the treatment of pulmonary arterial hypertension
Ropero, M. J. C., Cruz‐Utrilla, A., & Escribano-Subias, M. P. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1929925 · Cited by 9
Ţilea, I., Varga, A., Georgescu, A. M., & Grigorescu, B.-L. (2021) · The Journal of Critical Care Medicine · doi:10.2478/jccm-2021-0020 · Cited by 8
“Management of hypervolemia by venovenous ultrafiltration is retained in particular cases of hypervolemic PAH patients [16,93].”
BackgroundInfluentialCritser, P. J., Boyer, D. M., Visner, G. A., Collins, S. L., Fynn‐Thompson, F., & Mullen, M. P. (2022) · Pediatric Transplantation · doi:10.1111/petr.14236 · Cited by 8
Stącel, T., Antończyk, R., Latos, M., Nęcki, M., Przybyłowski, P., Zembala, M., Ochman, M., & Urlik, M. (2020) · Transplantation Proceedings · doi:10.1016/j.transproceed.2020.02.113 · Cited by 8
“Such treatment provides excellent results with 1-year survival of lung transplant recipients owing to severe pulmonary hypertension exceeding 90%, as reported by Hoeper et al [12].”
BackgroundBenazzo, A., Bajorek, L., Morscher, A., Schrutka, L., Schaden, E., Klepetko, W., Höetzenecker, K., Schwarz, S., Schweiger, T., Faybik, P., et al. (2021) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.05.034 · Cited by 8
Self-citationIntraoperative Circulatory Support in Lung Transplantation: Current Trend and Its Evidence
Starke, H., von Dossow, V., & Karsten, J. (2022) · Life · doi:10.3390/life12071005 · Cited by 8
“In advanced stages, end-organ damage such as renal failure, hepatic failure, and intestinal motility disorders can be observed [20,21].”
Background2022 Update of indications and contraindications for lung transplantation in France
Pavec, J. L., Pison, C. M., Hirschi, S., Bunel, V., Mordant, P., Brugière, O., Guen, M. L., Olland, A., Coiffard, B., Renaud-Picard, B., et al. (2022) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2022.100981 · Cited by 8
Self-citationFrick, A. E., Orlitová, M., Vanstapel, A., Ordies, S., Claes, S., Schols, D., Heigl, T., Kaes, J., Sáez, B., Vos, R., et al. (2021) · Intensive Care Medicine Experimental · doi:10.1186/s40635-021-00371-1 · Cited by 9
“[17] The impact of PA ow and physiological changes in the graft after reperfusion and in the early postoperative period is still debated.”
BackgroundAkutes Rechtsherzversagen auf der Intensivstation
Pilarczyk, K., Renner, J., & Haake, N. (2019) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-019-0603-6 · Cited by 7
Lee, S. Y., Ahn, J. H., Kim, H., Shim, T. S., Kang, P. J., Lee, G. D., Choi, S., Jung, S., Park, S.-I., & Hong, S. (2024) · Transplant International · doi:10.3389/ti.2024.12657 · Cited by 6
“Postoperative ECMO has been used in patients with unstable vital signs or hypoxemia at the end of surgery [6].”
BackgroundMethodInfluentialTransforming Pulmonary Arterial Hypertension: Key Milestones and Future Perspectives
Humbert, M. J. C., Zeder, K., Kovács, G., & Weatherald, J. C. (2026) · Circulation · doi:10.1161/circulationaha.126.079274 · Cited by 6
Pawar, S., Khan, N., Salam, A., Joshi, M., Saravanan, P. B., & Pandey, S. (2023) · Disease-a-Month · doi:10.1016/j.disamonth.2023.101635 · Cited by 8
Extracorporeal membrane oxygenation as a bridge to transplant in severe pulmonary hypertension
Kruszona, S., Aburahma, K., Wand, P., de Manna, N. D., Avsar, M., Bobylev, D., Müller, C., Carlens, J., Weymann, A., Schwerk, N., et al. (2024) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezae420 · Cited by 6
Dauriat, G., LePavec, J., Pradère, P., Savale, L., Fabre, D., & Fadel, É. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1842202 · Cited by 6
Self-citationParenteral prostanoids for severe Group 3 pulmonary hypertension with right ventricular dysfunction
Hinkamp, C. A., Shah, T. G., Bartolome, S., Torres, F., & Chin, K. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-20-1635 · Cited by 5
“Treatment is particularly challenging for patients with severe right ventricular (RV) failure, and overall outcomes are poor (10-12).”
BackgroundNew strategy to resume and taper epoprostenol after lung transplant for pulmonary hypertension
Ohsumi, A., Aoyama, A., Kinoshita, H., Yoneda, T., Yamazaki, K., Tanaka, S., Nakajima, D., Ikeda, T., Minatoya, K., & Date, H. (2022) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-021-01746-7 · Cited by 6
“, achieving a negative fluid balance, including the use of hemofiltration, as necessary, extended ECMO support), substantially reduces the occurrence of early graft dysfunction [9].”
BackgroundBalík, M., Rulíšek, J., Flaksa, M., Pořízka, M., Mošna, F., Lindner, J., Heller, S., Bělohlávek, J., Adla, T., Schmid, Ç., et al. (2022) · American Journal of Transplantation · doi:10.1111/ajt.16949 · Cited by 6
Management of Pulmonary Arterial Hypertension
Weatherald, J. C., Varughese, R. A., Liu, J., & Humbert, M. J. C. (2023) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0043-1770118 · Cited by 7
Implanting Impella 5.5 under Local Anesthesia
Eghbalzadeh, K., Wahlers, T., & Deppe, A. C. (2023) · The Thoracic and Cardiovascular Surgeon · doi:10.1055/a-2132-4694 · Cited by 6
Extracorporeal Life Support in Pulmonary Hypertension: Practical Aspects
Hoeper, M. M. (2023) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0043-1772752 · Cited by 6
Self-citationMartynyuk, T. V., Магомедовна, А. А., Rodnenkov, O. V., Zorin, A. V., Михайловна, К. А., Наконечников, С. Н., & Chazova, I. E. (2020) · Eurasian heart journal · doi:10.38109/2225-1685-2020-2-54-60 · Cited by 6
Advanced Circulatory Support and Lung Transplantation in Pulmonary Hypertension
Budev, M. M., & Yun, J. J. (2021) · Cardiology Clinics · doi:10.1016/j.ccl.2021.09.001 · Cited by 7
Scaravilli, V., Guzzardella, A., Madotto, F., Morlacchi, L. C., Bosone, M., Bonetti, C., Musso, V., Rossetti, V., Russo, F. M., Sorbo, L. D., et al. (2023) · Clinical Transplantation · doi:10.1111/ctr.15122 · Cited by 5
“24,29,30 In our cohort, we documented two cases of post-operative septic shock and hemorrhage requiring surgical revision, and no case of anaphylactic shock.”
BackgroundPradère, P., Pavec, J. L., Bos, S., Pozza, A., Nair, A., Meachery, G. J., Lordan, J. L., Humbert, M. J. C., Mercier, O. M., Fadel, É., et al. (2024) · ERJ Open Research · doi:10.1183/23120541.00521-2023 · Cited by 5
“Nevertheless, LT or HLT remain the reference treatment for end-stage disease [4, 6].”
BackgroundSelf-citationUeda, J., Tsuji, A., Aoki, T., Asano, R., Kiko, T., Hayashi, H., Endo, H., Nishi, N., Takano, R., Fujisaki, S., et al. (2025) · Circulation Reports · doi:10.1253/circrep.cr-24-0125 · Cited by 5
Predictive value of chest HRCT for survival in idiopathic pulmonary arterial hypertension
Kacprzak, A., Burakowska, B., Kurzyna, M., Fijałkowska, A., Florczyk, M., Wieteska, M., Darocha, S., Torbicki, A., & Szturmowicz, M. (2021) · Respiratory Research · doi:10.1186/s12931-021-01893-8 · Cited by 5
“There are few risk stratification tools, such as REVEAL score [29] and European Society of Cardiology (ESC)/European Respiratory Society (ERS) strategy [1], recommended for prognosis assessment [1, 28].”
BackgroundMethoddos Santos, P. R., Teixeira, P. J. Z., Neto, D. M. D. M., Langlais, B., & Cypel, M. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.02.009 · Cited by 6
Transplantation pulmonaire en France : actualisation des indications et contre-indications en 2022
Pavec, J. L., Pison, C. M., Hirschi, S., Bunel, V., Mordant, P., Brugière, O., Guen, M. L., Olland, A., Coiffard, B., Renaud-Picard, B., et al. (2022) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2022.10.005 · Cited by 5
Self-citationPichon, J., Roche, A., Fauvel, C., Boucly, A., Mercier, O. M., Ebstein, N., Beurnier, A., Cortese, J., Jevnikar, M., Jaïs, X., et al. (2023) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jead104 · Cited by 5
Self-citation
Metadata
- Authors
- Hoeper, M. M., Benza, R. L., Corris, P., de Perrot, M., Fadel, E., Keogh, A. M., Kühn, C., Savale, L., & Klepetko, W.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- Allegheny General Hospital (US)
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- UNSW Sydney (AU)
- Université Paris-Sud (FR)
- Medical University of Vienna (AT)
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801906
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351385
- OpenAlex
- W2904085911
- Semantic Scholar
- 0cb3e3a00226b18b6aafbe76418c4b8e0f8532ed
- Cited by
- 216
- References
- 81
- Citations by year
- 2026: 12 · 2025: 19 · 2024: 22 · 2023: 35 · 2022: 38 · 2021: 40 · 2020: 34 · 2019: 11
- FWCI
- 16.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Mechanical Circulatory Support Devices
- Keywords
- pulmonary hypertension, right ventricular support, lung transplantation, extracorporeal membrane oxygenation, bridge to transplant, right heart failure, fluid management, afterload, transplant candidate selection, graft failure prevention, perioperative care, intensive care
- MeSH terms
- Animals, Antihypertensive Agents, Cardiac Output, Echocardiography, Heart Failure, Humans, Hypertension, Pulmonary, Intensive Care Units, Extracorporeal Membrane Oxygenation, Lung Transplantation, Ventricular Dysfunction, Right, Disease Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.